27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
When Alexander Acosta resigned as Secretary of Labor, his deputy, Patrick Pizzella, took over as Act...
Read More >
Topics include legal considerations for: • 401(k) Plan participation: Designing a 401(k) plan to i...
Read More >
Whereas COVID-19 is likely to delay review timelines of many M&A deals, it may also make some approv...
Read More >
On November 20, 2019, the EEOC held a public hearing at its headquarters in Washington, DC, regardin...
Read More >
At what point does a company’s application of its anti-fraternization policy become sex discriminat...
Read More >
The California Court of Appeal, in its recent decision in Schmidt, et al. v. Superior Court, County ...
Read More >